I was thinking about a program to solve Sudoku.You fill a 9x9 grid with numbers from 1 to 9. The same number must not be ...
When studying programming, you notice something strange.Processes that are extremely complex for humans to think through can ...
See how modern search utilities add fuzzy matching, context highlights, and configurable result pipelines for speed.
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today. It is, perhaps, the ultimate promise of artificial intelligence: AI systems ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Anthropic co-founder Dario Amodei urges a deliberate slowdown in AI development, emphasizing ...
“Recursive self-improvement” is the idea that artificial intelligence could learn to build and train itself, creating exponential new progress — and risk. Jeff Clune, a computer scientist and ...
How do you get from a chatbot that sometimes makes things up to a machine that humans might struggle to control? There are several steps in that argument, and plenty of uncertainty. But an idea known ...
In the movie 'Robot', Rajnikant's character Dr Vaseegaran had to destroy his own creation 'Chitti' when it went out of control. AI makers face "Chitti problem" of uncontrollable AI. Concerns rise over ...
Recursive self-improvement could, in theory, lead to superintelligent AI. That is the short answer. The harder answer is that today's systems only show bounded, supervised self-refinement, not a ...
Anthropic and OpenAI researchers raised fresh concerns about recursive self-improvement, the process by which AI helps improve the development of models. Both OpenAI and Anthropic have in recent ...
AI agents are not yet creative enough to carry out genuinely innovative open-ended AI research, it seems. The AI industry’s boldest promise right now is that AI will soon improve itself, with almost ...
Recursion Pharmaceuticals, Inc. remains a Hold as competitive advances and slow revenue growth challenge its AI-driven drug discovery ambitions. RXRX's partnerships, notably with Genentech/Roche and ...